Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen vs Continuous Indomethacin for Patent Ductus Arteriosus
NCT00485160Phase 3Completed
- Sponsor
- Shaare Zedek Medical Center
- Start
- Feb 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of indomethacin, ibuprofen in patent ductus arteriosus (PDA), sponsored by Shaare Zedek Medical Center. Started Feb 2002; status: completed.
02
Drugs
indomethacinibuprofen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on NCT00485160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00485160.